Cogent Biosciences, Inc.

Biotechnology Research

Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging validated biology to advance precision therapies designed to address the true underlying drivers of disease and provide real hope for patients. Cogent�s lead therapeutic candidate, bezuclastinib (CGT9486), is a precision kinase inhibitor designed to selectively and potently inhibit the KIT D816V mutation. This mutation is responsible for driving a rare and serious condition called Systemic Mastocytosis which can severely impact many different tissues and organs in the body. We are also studying CGT9486 to treat advanced gastrointestinal stromal tumors (GIST), which have a strong dependence on oncogenic KIT signaling.

https://www.linkedin.com/company/cogentbiosciences/
From 2014
100 - 999

Website

vacancies

Open positions

Director, Corporate Counsel

Cogent Biosciences, Inc. Full Time

45 minutes ago

The Role:This is a broad, hands-on role for an attorney who will join a growing legal department and serve as counsel in connection with various types of contracts supporting business needs, including strategic transactions, research collaborations, services arrangements and other legal needs as the company transitions into a commercial-stage biotech company and its other pipeline programs evolve. The Corporate...